GPT and chronic myelogenous leukemia, BCR-ABL1 positive: Likewise, the CML-alleviated ALT level was significantly reduced by 5.1-times (p < 0.001), 6.5-times (p < 0.001), and 6.9-times (p < 0.001) in the DW-HDL, SO-HDL, and OSO-HDL groups, respectively, compared to the only CML injected group.